rs1805008

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002386.4(MC1R):​c.478C>T​(p.Arg160Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0685 in 1,606,068 control chromosomes in the GnomAD database, including 4,568 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R160Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.046 ( 207 hom., cov: 33)
Exomes 𝑓: 0.071 ( 4361 hom. )

Consequence

MC1R
NM_002386.4 missense

Scores

3
6
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:7O:3

Conservation

PhyloP100: 1.23

Publications

404 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002386.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057244897).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0754 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002386.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MC1R
NM_002386.4
MANE Select
c.478C>Tp.Arg160Trp
missense
Exon 1 of 1NP_002377.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MC1R
ENST00000555147.2
TSL:6 MANE Select
c.478C>Tp.Arg160Trp
missense
Exon 1 of 1ENSP00000451605.1Q01726
ENSG00000198211
ENST00000556922.1
TSL:2
c.478C>Tp.Arg160Trp
missense
Exon 1 of 5ENSP00000451560.1A0A0B4J269
MC1R
ENST00000555427.1
TSL:5
c.478C>Tp.Arg160Trp
missense
Exon 3 of 4ENSP00000451760.1G3V4F0

Frequencies

GnomAD3 genomes
AF:
0.0463
AC:
7051
AN:
152244
Hom.:
207
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0134
Gnomad AMI
AF:
0.102
Gnomad AMR
AF:
0.0135
Gnomad ASJ
AF:
0.0599
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.0610
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0772
Gnomad OTH
AF:
0.0287
GnomAD2 exomes
AF:
0.0472
AC:
11354
AN:
240724
AF XY:
0.0467
show subpopulations
Gnomad AFR exome
AF:
0.0129
Gnomad AMR exome
AF:
0.00819
Gnomad ASJ exome
AF:
0.0579
Gnomad EAS exome
AF:
0.0000558
Gnomad FIN exome
AF:
0.0643
Gnomad NFE exome
AF:
0.0800
Gnomad OTH exome
AF:
0.0427
GnomAD4 exome
AF:
0.0708
AC:
102907
AN:
1453706
Hom.:
4361
Cov.:
36
AF XY:
0.0687
AC XY:
49732
AN XY:
723538
show subpopulations
African (AFR)
AF:
0.0106
AC:
356
AN:
33474
American (AMR)
AF:
0.00830
AC:
371
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0563
AC:
1469
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00611
AC:
527
AN:
86236
European-Finnish (FIN)
AF:
0.0661
AC:
3020
AN:
45664
Middle Eastern (MID)
AF:
0.0172
AC:
99
AN:
5760
European-Non Finnish (NFE)
AF:
0.0843
AC:
93775
AN:
1111756
Other (OTH)
AF:
0.0546
AC:
3290
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
6589
13178
19766
26355
32944
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3422
6844
10266
13688
17110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0463
AC:
7052
AN:
152362
Hom.:
207
Cov.:
33
AF XY:
0.0439
AC XY:
3270
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0133
AC:
555
AN:
41596
American (AMR)
AF:
0.0135
AC:
206
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0599
AC:
208
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4832
European-Finnish (FIN)
AF:
0.0610
AC:
648
AN:
10622
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0772
AC:
5251
AN:
68032
Other (OTH)
AF:
0.0284
AC:
60
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
342
684
1025
1367
1709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0631
Hom.:
1252
Bravo
AF:
0.0412
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.0628
EpiControl
AF:
0.0681

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
2
Melanoma, cutaneous malignant, susceptibility to, 5 (2)
-
-
2
not specified (2)
-
-
1
Malignant tumor of breast (1)
1
-
-
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (1)
-
-
-
ALBINISM, OCULOCUTANEOUS, TYPE II, MODIFIER OF (1)
-
-
-
Increased analgesia from kappa-opioid receptor agonist, female-specific (1)
-
-
-
Skin/hair/eye pigmentation 2, red hair/fair skin (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
0.050
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.49
T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.57
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-0.62
T
MutationAssessor
Pathogenic
4.4
H
PhyloP100
1.2
PROVEAN
Pathogenic
-7.0
D
REVEL
Benign
0.27
Sift
Uncertain
0.010
D
Sift4G
Pathogenic
0.0010
D
Varity_R
0.36
gMVP
0.65
Mutation Taster
=93/7
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1805008;
hg19: chr16-89986144;
COSMIC: COSV59625425;
COSMIC: COSV59625425;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.